89bio, Inc. (ETNB) Tops Q3 EPS by 8c

89bio, Inc. (NASDAQ: ETNB) reported Q3 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Halozyme prices $1.3B convertible notes offering due 2033
• Could Affirm be a $200 stock?